Emmaus Life Sciences, Inc.
EMMA
$0.07
$0.019.23%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -77.88% | -91.59% | -16.10% | -108.50% | 35.58% |
| Total Depreciation and Amortization | 210.53% | 133.33% | 77.27% | 26.09% | -26.92% |
| Total Amortization of Deferred Charges | 64.25% | 99.68% | -20.90% | -67.06% | -80.05% |
| Total Other Non-Cash Items | 183.64% | 298.92% | 227.65% | 78.19% | -95.43% |
| Change in Net Operating Assets | 68.54% | 142.88% | 40.67% | 132.87% | 21.34% |
| Cash from Operations | 285.55% | 70.47% | 99.52% | -17.83% | -27.04% |
| Capital Expenditure | 66.67% | 87.50% | 91.67% | 41.67% | 53.85% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -27.26% | -13.40% | -13.40% | -13.40% | 2.99% |
| Cash from Investing | -27.28% | -13.30% | -13.16% | -13.10% | 3.53% |
| Total Debt Issued | 16.86% | 99.49% | 92.36% | 4.33% | -43.11% |
| Total Debt Repaid | -66.31% | -105.92% | -70.81% | -5.02% | 36.81% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -418.88% | -139.84% | -5.32% | -8.17% | -200.43% |
| Foreign Exchange rate Adjustments | -195.45% | -328.57% | 115.79% | -60.00% | 222.22% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 400.47% | 31.13% | 163.73% | -284.80% | -490.24% |